LDX Insider Trading

Insider Ownership Percentage: 30.29%
Insider Buying (Last 12 Months): A$39,875.00
Insider Selling (Last 12 Months): A$0.00

Lumos Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Lumos Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lumos Diagnostics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/29/2021 11:06 AM ET

This chart shows the closing price history over time for LDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Lumos Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2024Catherine RobsonInsiderBuy312,500A$0.03A$10,625.00
6/7/2024Samuel LanyonInsiderBuy250,000A$0.03A$7,500.00
10/18/2023Doug WardInsiderBuy250,000A$0.09A$21,750.00
8/3/2023Catherine RobsonInsiderIssued428,571A$0.07A$29,999.97
12/2/2022Catherine RobsonInsiderBuy71,072A$0.05A$3,553.60
11/30/2022Bronwyn Le GriceInsiderExpiry11,138A$0.05A$545.76
6/30/2022Catherine RobsonInsiderIssued109,349A$0.19A$20,776.31
10/28/2021Robert SamburskyInsiderIssued24,000A$1.25A$30,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Lumos Diagnostics (ASX:LDX)

23.40% of Lumos Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Lumos Diagnostics Holdings Limited, a contract research and development company, develops, manufactures, and commercializes rapid point-of-care (POC) diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. The company's products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Read More on Lumos Diagnostics

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Lumos Diagnostics?

Lumos Diagnostics' top insider investors include:
  1. Bronwyn Le Grice (Insider)
  2. Catherine Robson (Insider)
  3. Doug Ward (Insider)
  4. Samuel Lanyon (Insider)
Learn More about top insider investors at Lumos Diagnostics.